APA (7th ed.) Citation

Duaa S. Helal, Sara A. Darwish, Radwa A. Awad, Dina A. Ali, & Dina M. El-Guindy. (2023). Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: Association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival. BMC.

Chicago Style (17th ed.) Citation

Duaa S. Helal, Sara A. Darwish, Radwa A. Awad, Dina A. Ali, and Dina M. El-Guindy. Immunohistochemical Based Molecular Subtypes of Muscle-invasive Bladder Cancer: Association with HER2 and EGFR Alterations, Neoadjuvant Chemotherapy Response and Survival. BMC, 2023.

MLA (9th ed.) Citation

Duaa S. Helal, et al. Immunohistochemical Based Molecular Subtypes of Muscle-invasive Bladder Cancer: Association with HER2 and EGFR Alterations, Neoadjuvant Chemotherapy Response and Survival. BMC, 2023.